Quaife Matthew, Eakle Robyn, Cabrera Maria, Vickerman Peter, Tsepe Motlalepule, Cianci Fiona, Delany-Moretlwe Sinead, Terris-Prestholt Fern
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
BMJ Open. 2016 Jun 27;6(6):e010682. doi: 10.1136/bmjopen-2015-010682.
For the past few decades, condoms have been the main method of HIV prevention. Recent advances in antiretroviral (ARV)-based prevention products have substantially changed the prevention landscape, yet little is known about how popular these products will be among potential users, or whether new methods might be used in conjunction with, or instead of, condoms. This study will use a discrete choice experiment (DCE) to (1) explore potential users' preferences regarding HIV prevention products, (2) quantify the importance of product attributes and (3) predict the uptake of products to inform estimates of their potential impact on the HIV epidemic in South Africa. We consider preferences for oral pre-exposure prophylaxis; a vaginal microbicide gel; a long-acting vaginal ring; a SILCS diaphragm used in concert with gel; and a long-acting ARV-based injectable.
This study will gather data from 4 populations: 200 women, 200 men, 200 adolescent girls (aged 16-17 years) and 200 female sex workers. The DCE attributes and design will be developed through a literature review, supplemented by a thematic analysis of qualitative focus group discussions. Extensive piloting will be carried out in each population through semistructured interviews. The final survey will be conducted using computer tablets via a household sample (for women, men and adolescents) and respondent-driven sampling (for female sex workers), and DCE data analysed using a range of multinomial logit models.
This study has been approved by the University of the Witwatersrand Human Research Ethics Committee and the Research Ethics Committee at the London School of Hygiene and Tropical Medicine. Findings will be presented to international conferences and peer-reviewed journals. Meetings will be held with opinion leaders in South Africa, while results will be disseminated to participants in Ekurhuleni through a public meeting or newsletter.
在过去几十年里,避孕套一直是预防艾滋病毒的主要方法。基于抗逆转录病毒(ARV)的预防产品的最新进展已极大地改变了预防格局,但对于这些产品在潜在用户中的受欢迎程度,或者新方法是否会与避孕套联合使用或取而代之,人们却知之甚少。本研究将采用离散选择实验(DCE)来:(1)探索潜在用户对艾滋病毒预防产品的偏好;(2)量化产品属性的重要性;(3)预测产品的采用情况,以了解其对南非艾滋病毒流行的潜在影响。我们考虑了对口服暴露前预防、阴道杀菌剂凝胶、长效阴道环、与凝胶配合使用的SILCS隔膜以及基于长效抗逆转录病毒的注射剂的偏好。
本研究将从4类人群中收集数据:200名女性、200名男性、200名青少年女孩(16 - 17岁)和200名女性性工作者。DCE的属性和设计将通过文献综述来确定,并辅以对定性焦点小组讨论的主题分析。将通过半结构化访谈在每个人群中进行广泛的预试验。最终调查将通过家用电脑平板进行,针对女性、男性和青少年采用家庭抽样,针对女性性工作者采用应答驱动抽样,并且使用一系列多项logit模型分析DCE数据。
本研究已获得威特沃特斯兰德大学人类研究伦理委员会以及伦敦卫生与热带医学院研究伦理委员会的批准。研究结果将在国际会议上展示并发表在同行评审期刊上。将与南非的意见领袖举行会议,同时通过公开会议或时事通讯将结果传播给埃库鲁莱尼的参与者。